ArticleJournal of surgical case reports2026
Implementation of transoral robotic thyroid surgery in a European tertiary center.
Article in Journal of surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Transoral thyroidectomy via vestibular approach has gained increasing acceptance due to its excellent cosmetic outcomes. Transoral robotic thyroidectomy (TORT) represents a further technical evolution, potentially offering enhanced options of instrument movement and visualization. However, no reports from Europe were yet published. We report the first TORT performed in Germany in a 56-year-old female presenting with a symptomatic 20 × 16 mm sized nodule in the right thyroid lobe measuring 14 ml. A right hemithyroidectomy was performed using TORT with the daVinci Xi® robotic system. Total operative time was 230 min. The postoperative course was uneventful, and the patient was discharged on postoperative day 3. TORT is feasible and safe in selected patients also in the German hospital setting, although the additional costs are not reimbursed by the German health system. This case demonstrates the technical applicability and highlights key procedural steps for implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.